Total Payments
$176,315
2024 Payments
$125.97
Companies
16
Transactions
191
Medicare Patients
485
Medicare Billing
$216,066
Payment Breakdown by Category
Other$149,434 (84.8%)
Travel$10,943 (6.2%)
Consulting$10,293 (5.8%)
Food & Beverage$5,153 (2.9%)
Education$491.95 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $148,869 | 66 | 84.4% |
| Travel and Lodging | $10,943 | 49 | 6.2% |
| Consulting Fee | $10,293 | 6 | 5.8% |
| Food and Beverage | $5,153 | 64 | 2.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $565.00 | 1 | 0.3% |
| Education | $491.95 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $65,765 | 60 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $29,753 | 27 | $0 (2021) |
| Celgene Corporation | $28,006 | 31 | $0 (2021) |
| Amgen Inc. | $18,847 | 24 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $15,213 | 10 | $0 (2022) |
| Millennium Pharmaceuticals, Inc. | $14,277 | 14 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $3,385 | 3 | $0 (2017) |
| Astellas Pharma US Inc | $392.95 | 4 | $0 (2023) |
| Janssen Biotech, Inc. | $174.65 | 3 | $0 (2022) |
| GENZYME CORPORATION | $125.97 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.97 | 1 | GENZYME CORPORATION ($125.97) |
| 2023 | $2,240 | 6 | Amgen Inc. ($2,058) |
| 2022 | $15,388 | 14 | E.R. Squibb & Sons, L.L.C. ($15,213) |
| 2021 | $15,650 | 24 | Amgen Inc. ($11,324) |
| 2020 | $17,444 | 20 | Takeda Pharmaceuticals U.S.A., Inc. ($11,873) |
| 2019 | $64,630 | 64 | Takeda Pharmaceuticals U.S.A., Inc. ($34,068) |
| 2018 | $36,950 | 36 | Takeda Pharmaceuticals U.S.A., Inc. ($19,725) |
| 2017 | $23,887 | 26 | Millennium Pharmaceuticals, Inc. ($14,277) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $125.97 | General |
| Category: Oncology | ||||||
| 12/04/2023 | Amgen Inc. | Blincyto (Biological) | Consulting Fee | Cash or cash equivalent | $2,058.00 | General |
| Category: Oncology | ||||||
| 05/25/2023 | PFIZER INC. | BESPONSA (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2023 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: BioOncology | ||||||
| 03/23/2023 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $29.97 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2023 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $21.12 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $95.00 | General |
| 11/08/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Oncology | ||||||
| 09/28/2022 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,665.00 | General |
| 09/27/2022 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $39.25 | General |
| 09/21/2022 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA | ||||||
| 09/15/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $122.17 | General |
| 09/14/2022 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,665.00 | General |
| 08/25/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $121.01 | General |
| 08/04/2022 | PFIZER INC. | BESPONSA (Biological), PAXLOVID | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2022 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $38.61 | General |
| 06/08/2022 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,665.00 | General |
| 05/19/2022 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $124.81 | General |
| 02/23/2022 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,665.00 | General |
| Category: Hematology | ||||||
| 02/10/2022 | E.R. Squibb & Sons, L.L.C. | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $106.97 | General |
| Category: Hematology | ||||||
| 01/17/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 12/07/2021 | Celgene Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| 11/30/2021 | Alexion Pharmaceuticals, Inc. | Ultomiris (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Immunology | ||||||
| 11/24/2021 | Celgene Corporation | — | Travel and Lodging | Cash or cash equivalent | $1,074.80 | General |
| 11/05/2021 | Amgen Inc. | Blincyto (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $531.25 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 95 | 417 | $156,265 | $41,176 |
| 2022 | 3 | 126 | 680 | $214,386 | $56,354 |
| 2021 | 3 | 125 | 730 | $214,583 | $62,163 |
| 2020 | 4 | 139 | 653 | $209,142 | $56,373 |
Total Patients
485
Total Services
2,480
Medicare Billing
$216,066
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 80 | 400 | $151,600 | $40,027 | 26.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 17 | $4,665 | $1,149 | 24.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 85 | 452 | $150,516 | $39,455 | 26.2% |
| 99356 | Extended inpatient or observation hospital service, first hour | Facility | 2022 | 16 | 186 | $54,126 | $14,327 | 26.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 42 | $9,744 | $2,573 | 26.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 79 | 525 | $161,175 | $46,908 | 29.1% |
| 99356 | Prolonged inpatient or observation hospital service, first hour | Facility | 2021 | 20 | 163 | $44,336 | $12,820 | 28.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 42 | $9,072 | $2,434 | 26.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 73 | 470 | $160,270 | $42,781 | 26.7% |
| 99356 | Prolonged inpatient or observation hospital service first hour | Facility | 2020 | 16 | 109 | $32,918 | $8,830 | 26.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 39 | 62 | $14,694 | $3,924 | 26.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 11 | 12 | $1,260 | $839.16 | 66.6% |
About Dr. Lyle Feinstein, MD
Dr. Lyle Feinstein, MD is a Hematology & Oncology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1871589416.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lyle Feinstein, MD has received a total of $176,315 in payments from pharmaceutical and medical device companies, with $125.97 received in 2024. These payments were reported across 191 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($148,869).
As a Medicare-enrolled provider, Feinstein has provided services to 485 Medicare beneficiaries, totaling 2,480 services with total Medicare billing of $216,066. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Miami, FL
- Active Since 09/20/2005
- Last Updated 03/30/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1871589416
Products in Payments
- NINLARO (Drug) $79,943
- RYDAPT (Drug) $27,873
- Revlimid (Drug) $24,843
- Blincyto (Biological) $18,023
- Pomalyst (Drug) $4,444
- NOXAFIL (Drug) $3,385
- Kyprolis (Biological) $823.84
- DARZALEX (Biological) $237.75
- SARCLISA (Biological) $125.97
- clonoSEQ (Device) $83.03
- LEUKINE (Drug) $54.87
- Ultomiris (Drug) $47.71
- BESPONSA (Biological) $34.02
- ERLEADA (Drug) $26.04
- ELIQUIS (Drug) $24.81
- IMBRUVICA (Drug) $23.62
- Venclexta (Biological) $18.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Miami
Dr. Steven Fein, M.d, M.D
Hematology & Oncology — Payments: $1.4M
Hematology & Oncology $1.4M
Carl Landgren, Md, MD
Hematology & Oncology — Payments: $751,068
Hematology & Oncology $751,068
Dr. Fernando De Zarraga, M.d, M.D
Hematology & Oncology — Payments: $649,574
Hematology & Oncology $649,574
Mr. Neil Nagovski, Md, MD
Hematology & Oncology — Payments: $533,284
Hematology & Oncology $533,284
Srikanth Nagalla, Md, MD
Hematology & Oncology — Payments: $510,589
Hematology & Oncology $510,589
Raja Mudad, Md, MD
Hematology & Oncology — Payments: $442,163
Hematology & Oncology $442,163